
Photo by mohamed hassan form PxHere
A world-first trial has shown that nose drops of modified ‘friendly’ bacteria protect against meningitis.
Led by Professor Robert Read and Dr Jay Laver from the NIHR Southampton Biomedical Research Centre and the University of Southampton, the work is the first of its kind.
Together they inserted a gene into a harmless type of a bacteria, that allows it to remain in the nose and trigger an immune response. They then introduced these bacteria into the noses of healthy volunteers via nose drops.
The results, published in the journal Science Translational Medicine, showed a strong immune response against bacteria that cause meningitis and long-lasting protection.
Protecting against meningitis
Meningitis occurs in people of all age groups but affects mainly infants, young children and the elderly. Meningococcal meningitis, is a bacterial form of the disease, causing 1,500 cases a year in the UK. It can lead to death in as little as four hours after symptoms start.
Around 10% of adults carry N. meningitidis in the back of their nose and throat with no signs or symptoms. However, in some people it can invade the bloodstream. That can lead to life-threatening conditions including meningitis and blood poisoning (‘septicaemia).
The ‘friendly’ bacteria Neisseria lactamica (N. lactamica) also lives in some people’s noses naturally. By occupying the nose, it protects from a severe type of meningitis. It does so by denying a foothold to its close cousin Neisseria meningitidis (N. meningitidis).
Enhanced immune response
The new data build on the team’s previous work aiming to exploit this natural phenomenon. That study showed nose drops of N. lactamica prevented N. meningitidis from settling in 60% of participants.
For those people, N. lactamica had locked out its deadly cousin. That drove work to make N. lactamica even more effective in displacing N. meningitidis.
The team did so by handing it one of N. meningitidis’ key weapons; a ‘sticky’ surface protein that grips the cells lining the nose. By inserting a copy of the gene for this protein into N. lactamica’s DNA, it could produce it too – levelling the playing field.
As well as inducing a stronger immune response, those modified bacteria stayed longer. Present for at least 28 days, with most participants (86%) still carrying it at 90 days, it caused no adverse symptoms.
The results of the study, which was funded by the Medical Research Council, are promising for this new way of preventing life-threatening infections, without drugs. It’s an approach that could be critical in the face of growing antimicrobial resistance.
Dr Jay Laver, Senior Research Fellow in Molecular Microbiology at the University of Southampton, commented: “Although this study has identified the potential of our recombinant N. lactamica technology for protecting people against meningococcal disease, the underlying platform technology has broader applications.
“It is theoretically possible to express any antigen in our bacteria, which means we can potentially adapt them to combat a multitude of infections that enter the body through the upper respiratory tract. In addition to the delivery of vaccine antigens, advances in synthetic biology mean we might also use genetically modified bacteria to manufacture and deliver therapeutics molecules in the near future.”
Prof Read, Director of the NIHR Southampton Biomedical Research Centre said: “This work has shown that it is possible to protect people from severe diseases by using nose drops containing genetically modified friendly bacteria. We think this is likely to be a very successful and popular way of protecting people against a range of diseases in the future.”
Original Article: People given ‘friendly’ bacteria in nose drops protected against meningitis
More from: University of Southampton
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Meningitis
- Professional golfer, St. Rita's alum honored by school for positive impact, inspiration on and off the links
Professional golfer Kevin Hall lost his hearing at 2-years-old from meningitis. A year later, his parents enrolled him at St. Rita School for the Deaf, and he continued his education there for the ...
- Meningitis: Avoid overcrowded, poorly ventilated areas, doctor cautions
Dr Chioma Ofoekii, a medical practitioner, has advised that people should avoid overcrowding and poor ventilation during hot season to prevent meningitis.
- Meningitis: Avoid overcrowded, poorly ventilated areas, doctor cautions Nigerians
According to her, meningitis can be infectious or non-infectious, with viruses accounting for the majority of the infectious type.
- A Review of Pediatric Bacterial Meningitis
Pediatric bacterial meningitis is a medical emergency requiring immediate initiation of treatment. Although the United States and other developed countries have seen a decline in pediatric ...
- Meningitis signs and symptoms as cases of potentially deadly illness on the rise
The charity Meningitis Now has urged people to be aware of the warning signs. A leading meningitis charity has urged people to be aware of some of the early warning signs and symptoms of disease, ...
Go deeper with Google Headlines on:
Meningitis
[google_news title=”” keyword=”meningitis” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Genetically modified friendly bacteria
- Monsanto Grows Controversy on Genetically Modified Food
The world's largest seed company won in Washington state but lost in Washington, D.C. The battle over the role of government in genetically modified foods will continue. The world's largest seed ...
- Genetically Modified Food News, Research and Latest Updates
Keep abreast with the latest news related to Genetically Modified Food there are 127 news items on Genetically Modified Food that covers updates, breakthroughs and in-depth reports. We provide you ...
- Chernobyl’s Dogs Are Genetically Distinct
The post Chernobyl’s Dogs Are Genetically Distinct appeared first on DogTime.
- Group Approves Genetically Modified Cowpea
The Nigerian Biosafety Management Agency (NBMA) has approved the commercial release of genetically modified, pest-resistant cowpea to farmers in Nigeria. This places the country on the path to ...
- Fact check: Video shows aphid, not genetically modified mosquito stamped with number
The video doesn't show a genetically modified mosquito, but they do exist. They're mass-produced in labs to control mosquito populations and prevent outbreaks of disease, according to the Centers ...
Go deeper with Google Headlines on:
Genetically modified friendly bacteria
[google_news title=”” keyword=”genetically modified friendly bacteria” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]